Viewing Study NCT03526315



Ignite Creation Date: 2024-05-06 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 12:45 PM
Study NCT ID: NCT03526315
Status: COMPLETED
Last Update Posted: 2018-05-16
First Post: 2017-03-06

Brief Title: Antimicrobial Effect of Different Pastes on Streptococcus Mutans in Children
Sponsor: Jordan University of Science and Technology
Organization: Jordan University of Science and Technology

Study Overview

Official Title: Antimicrobial Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Streptococcus Mutans in Children
Status: COMPLETED
Status Verified Date: 2018-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is a randomized controlled trial involving 127 children ages between 4 and 5 years to investigate the efficacy of Casein Phosphopeptide-Amorphous Calcium Phosphate CPP-ACP in reducing Streptococcus mutans S mutans bacteria and compare that with fluoride alone or combined use of fluoride and CPP-ACP over a 6 month period using Saliva Check Mutans kits to detect Mutans Streptococci MS It is expected that all used anti-cariogenic agents will have the ability to reduce the S mutans level in different values
Detailed Description: Aim The aim of this study is to investigate the efficacy of CPP-ACP in reducing S mutans and compare that with fluoride alone or combined use of fluoride and CPP-ACP

Materials and methods This study is a randomized controlled trial involving 127 children ages between 4 and 5 years They will be examined and chosen randomly for the study One hundred and twenty seven children will be divided equally into three groups Group 1 will use CPP-ACP twice daily Group 2 will apply fluoride toothpaste twice daily Group 3 will apply fluoridated toothpaste and CPP-ACP twice daily Oral swabs will be collected from children to measure S mutans levels in terms of Colony forming units CFU using Saliva Check Mutans kits GC Asia for this purpose Samples will be analyzed for S mutans colonization before antibacterial agent application baseline and at 3 and 6 month intervals

Expected results it is expected that all used anti-cariogenic agents will have the ability to reduce the S mutans levels in different levels

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None